# BILPREVDA
> **BLA761444** · Biologics License Application · Sponsor: SHANGHAI HENLIUS BIOTECH · Approved 2025-08-29
## Drug
- **FDA Application Number:** BLA761444
- **Application type:** Biologics License Application
- **Brand name:** BILPREVDA
- **Generic name:** DENOSUMAB
- **Active ingredients:** DENOSUMAB-NXXP
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SHANGHAI HENLIUS BIOTECH
- **Manufacturer:** Organon LLC
- **First approval:** 2025-08-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761444)
---
*MORVS · CC0 1.0*